According to the new market research report sterility testing market
is expected to reach USD 941.0 Million by 2021 from USD 528.0 Million
in 2016, at a CAGR of 12.3% from 2016 to 2021. The growth of the
sterility testing market can be attributed to the growth in the
pharmaceutical and biotechnology industries, increase in the number of
new drug launches, and increasing R&D in life science research.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208866931
Market Dynamics
Drivers
Growth of pharmaceutical & biotechnology companies
Increasing number of drug launches
Government support for pharmaceutical and biotechnology industries
Increasing R&D investment in life sciences
Restraints
High degree of consolidation, major barrier for new market entrants
Stringent regulatory frameworks and time-consuming approval processes
Opportunities
Emerging markets
Increasingly pharmaceutical outsourcing
Challenges
Shortage of skilled professionals
Major players in the sterility testing market include Merck KGaA
(Germany), Charles River Laboratories International, Inc. (U.S.),
bioMérieux SA (France), SGS S.A. (Switzerland), Sartorius AG (Germany),
WuXi AppTec (China), Nelson Laboratories (U.S.), Danaher Corporation
(U.S.), Pacific Biolabs (U.S.), Toxikon Corporation (U.S.), and Thermo
Fisher Scientific, Inc. (U.S.).
• Based on product, the market
is segmented into kits and reagents, instruments, and services. The kits
and reagents segment are the largest and the fastest-growing product
segment in the sterility testing market. The large share of the kits and
reagents segment can be attributed to the requirement of the repeat
purchase of these products, coupled with the increasing preference for
kit-based testing.
• Based on test, the market is segmented into
membrane filtration, direct inoculation, and other sterility tests. The
membrane filtration segment is estimated to account for the largest
share of the sterility testing market in 2016. The large share of this
segment can primarily be attributed to rapid growth in the
pharmaceutical and biotechnology end-use industry.
• Based on
application, the market is segmented into pharmaceutical and biological
manufacturing, medical devices manufacturing, and other applications.
The pharmaceutical and biological manufacturing segment is projected to
witness the highest growth in this market due to the rapid growth in the
pharma and biotech industries.
Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=208866931
Based on region, the global sterility testing market is segmented into
North America, Europe, Asia, and the Rest of the World (RoW). The market
is dominated by North America, followed by Europe, Asia, and the Rest
of the World (RoW). However, the Asian market will witness the highest
growth during the forecast period, primarily due to the increasing
expenditure on life science research in the region and growing trend of
pharmaceutical outsourcing to Asian countries like India and China.
Growth in the outsourcing industry in Asia is another major factor
supporting overall market growth in the region. The rapidly increasing
demand for the outsourcing of microbial testing in countries such as
China, India, Japan, and Singapore is expected to drive market growth
during the forecast period. To capitalize on the opportunities in the
Asian market, a number of companies have worked to increase their market
share and customer base in the region.
